English  |  正體中文  |  简体中文  |  总笔数 :2875219  
造访人次 :  54062746    在线人数 :  1677
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

跳至: [ 中文 ] [ 数字0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
请输入前几个字:   

显示项目 534951-534960 / 2351361 (共235137页)
<< < 53491 53492 53493 53494 53495 53496 53497 53498 53499 53500 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
國立臺灣科技大學 2014-04 iWash 馬彗娟;程彥彰;馮睦淳
國立臺灣科技大學 2014-04 iWash 馬彗娟;程彥彰;馮睦淳
臺大學術典藏 2020-01-06T03:05:27Z IWMCG-4 - Proceedings of the Fourth International Workshop on Modeling in Crystal Growth - 4-7 November 2003 - Kyushu, Japan - Preface Lan, C. W.; Imaishi, N.; Kakimoto, K.; CHUNG-WEN LAN
國立成功大學 2005-01 IWR: Interactive WWW response in the wireless and mobile environment using the concept of universal WWW access Huang, Chung-Ming; Chao, Yu-Chang
國立臺灣科技大學 2007 IWTRP: Spatial-reuse enhancement of the wireless token ring protocol Cheng, R.-G.;Chang, R.-I.;Hua, K.-L.
中山醫學大學 2020 Ixekizumab for the treatment of ankylosing spondylitis Huang, JX; Lee, YH; Wei, JCC
臺大學術典藏 2018-09-10T18:07:35Z Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial Nash, P. and Kirkham, B. and Okada, M. and Rahman, P. and Combe, B. and Burmester, G.-R. and Adams, D.H. and Kerr, L. and Lee, C. and Shuler, C.L. and Genovese, M. and Ahmed, K. and Alper, J. and Barkham, N. and Bennett, R.E. and Garc\\'ia, F.J.B. and Alonso, R.B. and Blumstein, H.B. and Brooks, M.S. and Burmester, G.-R. and Cagnoli, P. and Caldron, P.H. and Cantagrel, A. and Chen, D.-Y. and Churchill, M.A. and Codding, C.E. and Combe, B. and Deane, P.M.G. and Del Giudice, J. and Deodhar, A.A. and Dhar, R.K. and Dokoupilova, E. and Egan, R.M. and Everding, A. and Gal\\'indez, E. and Genovese, M. and Goddard, D.H. and Gottlieb, A. and Goupille, P. and Griffin, R.M. and Gupta, R.C. and Hall, S. and Hatti, K. and Howell, M.P. and Huang, Y.-H. and Jajoo, R. and Janssen, N.M. and Kiltz, U. and Kivitz, A.J. and Klein, S.J. and Korkosz, M.P. and Kotha, R. and Kremer, J.M. and Lue, C. and de la Fuente, J.L.M. and Marzo-Ortega, H. and Masmitja, J.G. and Mease, P.J. and Meroni, P.L. and Mueller, E.C. and Nandagudi, A.C. and Nash, P. and Fern\\'andez-Nebro, A. and Neuwelt, C.M. and Orbai, A.M. and Oza, M.R. and Parks, D.L. and Pattanaik, D. and Rell-Bakalarska, M.E. and Rosmarin, D. and Roussou, E. and Rychlewska-Hanczewksa, A.I. and Sikes, D.H. and Stack, M.T. and Sunkureddi, P. and Tahir, H. and Tha?i, D. and Tsai, T.-F. and Turkiewicz, A.M. and Unger, L. and Cabello, R.V. and Wagner, U. and Wei, C.-C. and Wells, A.F. and Youssef, P. and Zielinska, A.; TSEN-FANG TSAI
臺大學術典藏 2020-10-22T07:27:50Z Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial Okada M.; Kirkham B.; Nash P.; Nash P.;Kirkham B.;Okada M.;Rahman P.;Combe B.;Burmester G.-R.;Adams D.H.;Kerr L.;Lee C.;Shuler C.L.;Genovese M.;Ahmed K.;Alper J.;Barkham N.;Bennett R.E.;Garc?A F.J.B.;Alonso R.B.;Blumstein H.B.;Brooks M.S.;Burmester G.-R.;Cagnoli P.;Caldron P.H.;Cantagrel A.;Chen D.-Y.;Churchill M.A.;Jr, Codding C.E.;Combe B.;Deane P.M.G.;Del Giudice J.;Deodhar A.A.;Dhar R.K.;Dokoupilova E.;Egan R.M.;Everding A.;Gal?Ndez E.;Genovese M.;Goddard D.H.;Gottlieb A.;Goupille P.;Griffin R.M.;Gupta R.C.;Hall S.;Hatti K.;Howell M.P.;Huang Y.-H.;Jajoo R.;Janssen N.M.;Kiltz U.;Kivitz A.J.;Klein S.J.;Korkosz M.P.;Kotha R.;Kremer J.M.;Lue C.;De La Fuente J.L.M.;Marzo-Ortega H.;Masmitja J.G.;Mease P.J.;Meroni P.L.;Mueller E.C.;Nandagudi A.C.;Nash P.;Fern?Ndez-Nebro A.;Neuwelt C.M.;Orbai A.M.;Oza M.R.;Parks D.L.;Pattanaik D.;Rell-Bakalarska M.E.;Rosmarin D.;Roussou E.;Rychlewska-Hanczewksa A.I.;Sikes D.H.;Stack M.T.;Sunkureddi P.;Tahir H.;Tha?I D.;Tsen-Fang Tsai;Turkiewicz A.M.;Unger L.;Cabello R.V.;Wagner U.;Wei C.-C.;Wells A.F.;Youssef P.;Zielinska A.; Korkosz M.P.; Klein S.J.; Kiltz U.; Kivitz A.J.; Janssen N.M.; Rahman P.; Combe B.; Burmester G.-R.; Adams D.H.; Kerr L.; Lee C.; Shuler C.L.; Genovese M.; Ahmed K.; Alper J.; Barkham N.; Bennett R.E.; Garc?a F.J.B.; Alonso R.B.; Blumstein H.B.; Brooks M.S.; Burmester G.-R.; Cagnoli P.; Caldron P.H.; Cantagrel A.; Chen D.-Y.; Churchill M.A.; Jr, Codding C.E.; Combe B.; Deane P.M.G.; Del Giudice J.; Deodhar A.A.; Dhar R.K.; Dokoupilova E.; Egan R.M.; Everding A.; Gal?ndez E.; Genovese M.; Goddard D.H.; Gottlieb A.; Goupille P.; Griffin R.M.; Gupta R.C.; Hall S.; Hatti K.; Howell M.P.; Huang Y.-H.; Jajoo R.; Zielinska A.; Wells A.F.; Youssef P.; Kotha R.; Kremer J.M.; Lue C.; de la Fuente J.L.M.; Marzo-Ortega H.; Masmitja J.G.; Mease P.J.; Meroni P.L.; Mueller E.C.; Nandagudi A.C.; Nash P.; Fern?ndez-Nebro A.; Neuwelt C.M.; Orbai A.M.; Oza M.R.; Parks D.L.; Pattanaik D.; Rell-Bakalarska M.E.; Rosmarin D.; Roussou E.; Rychlewska-Hanczewksa A.I.; Sikes D.H.; Stack M.T.; Sunkureddi P.; Tahir H.; Tha?i D.; TSEN-FANG TSAI; Turkiewicz A.M.; Unger L.; Cabello R.V.; Wagner U.; Wei C.-C.
中山醫學大學 2021 Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies Kiltz, U; Wei, JCC; van der Heijde, D; van den Bosch, F; Walsh, JA; Boonen, A; Gensler, LS; Hunter, T; Carlier, H; Dong, Y; Li, XQ; Bolce, R; Strand, V; Braun, J
臺大學術典藏 2021-10-28T07:11:15Z Ixekizumab, with or without concomitant methotrexate, improves signs and symptoms of PsA: week 52 results from Spirit-P1 and Spirit-P2 studies Combe B.; TSEN-FANG TSAI; Huffstutter J.E.; Sprabery A.T.; Lin C.-Y.; Park S.Y.; Kronbergs A.; Hufford M.M.; Nash P.

显示项目 534951-534960 / 2351361 (共235137页)
<< < 53491 53492 53493 53494 53495 53496 53497 53498 53499 53500 > >>
每页显示[10|25|50]项目